Concurrent chronic myeloid leukemia and CALR-mutated chronic myeloproliferative neoplasm
Blood Cells Mol Dis
.
2020 Mar:81:102395.
doi: 10.1016/j.bcmd.2019.102395.
Epub 2019 Nov 30.
Authors
Francesca Guidotti
1
,
Angelo Gardellini
2
,
Maddalena Feltri
3
,
Michelle Zancanella
2
,
Vittoria Saccà
2
,
Franco Alberio
2
,
Luciana Ambrosiani
3
,
Mauro Turrini
2
Affiliations
1
Division of Hematology, Department of Medicine, Valduce Hospital, Como, Italy. Electronic address: francesca_guidotti@yahoo.it.
2
Division of Hematology, Department of Medicine, Valduce Hospital, Como, Italy.
3
Department of Pathology, Valduce Hospital, Como, Italy.
PMID:
31816513
DOI:
10.1016/j.bcmd.2019.102395
No abstract available
Publication types
Letter
MeSH terms
Calreticulin / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
Mutation
Myeloproliferative Disorders / complications*
Myeloproliferative Disorders / genetics
Neoplasms
Substances
Calreticulin